Perspective Therapeutics SG&A Expense (Annual) Insights

Perspective Therapeutics Inc (CATX)

1.60 +0.07 (+4.58%) USD | NYAM | May 17, 16:00

1.595 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 1994. Upgrade now.

Date	Value
December 31, 2023	21.06M
December 31, 2022	7.107M
June 30, 2022	9.425M
June 30, 2021	7.131M
June 30, 2020	7.547M
June 30, 2019	6.851M
June 30, 2018	6.825M
June 30, 2017	6.23M
June 30, 2016	5.139M
June 30, 2015	3.889M
June 30, 2014	3.723M
June 30, 2013	3.590M
June 30, 2012	3.571M
June 30, 2011	3.655M
June 30, 2010	4.394M
June 30, 2009	5.159M

Date	Value
June 30, 2008	7.293M
June 30, 2007	8.300M
June 30, 2006	4.924M
June 30, 2005	30.13M
September 30, 2004	0.0091M
September 30, 2003	0.019M
September 30, 2002	0.0076M
September 30, 2001	0.0156M
September 30, 2000
September 30, 1999	0.0155M
September 30, 1998	0.2219M
September 30, 1997	0.2979M
September 30, 1996	2.589M
September 30, 1995	1.243M
September 30, 1994	1.227M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

6.851M

Minimum

2019

21.06M

Maximum

2023

9.854M

Average

7.339M

Median

SG&A Expense (Annual) Benchmarks